Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
405,051
-
Share change
-
-251,851
-
Total reported value
-
$1,385,659
-
Price per share
-
$3.42
-
Number of holders
-
16
-
Value change
-
-$652,595
-
Number of buys
-
10
-
Number of sells
-
5
Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q3 2023
As of 30 Sep 2023,
Immix Biopharma, Inc. - Common Stock (IMMX) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
405,051 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Koshinski Asset Management, Inc., STATE STREET CORP, COMMONWEALTH EQUITY SERVICES, LLC, Imprint Wealth LLC, Moss Adams Wealth Advisors LLC, BlackRock Inc., InterOcean Capital Group, LLC, and TOCQUEVILLE ASSET MANAGEMENT L.P..
This page lists
16
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.